Literature DB >> 17227634

Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.

Hiroshi Saito1.   

Abstract

Japan has had a programme of colorectal cancer screening with immunochemical faecal occult blood testing since 1992. Participation rates are around 17%. Approximately 7% of subjects test positive and, of these, around 60% comply with the request to undergo further diagnostic testing. Colorectal cancer rates have been increasing rapidly in Japan in recent decades, and there is an urgent need to improve participation rates.

Entities:  

Mesh:

Year:  2006        PMID: 17227634

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  23 in total

1.  Factors associated with participation in colorectal cancer screening in Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).

Authors:  Jun-Pyo Myong; Jin-Yong Shin; Su-Jin Kim
Journal:  Int J Colorectal Dis       Date:  2012-02-22       Impact factor: 2.571

Review 2.  [International status colorectal cancer screening and quality assurance of screening-colonoscopy].

Authors:  Nikolaus Patera; Claudia Wild
Journal:  Wien Med Wochenschr       Date:  2013-09-05

3.  Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.

Authors:  Hironori Kumagai; Wellington Pham; Makoto Kataoka; Ken-Ichiro Hiwatari; James McBride; Kevin J Wilson; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Eric H Liu; John C Gore; Shinji Sakuma
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

4.  A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals.

Authors:  Masau Sekiguchi; Yasuo Kakugawa; Minori Matsumoto; Takahisa Matsuda
Journal:  J Gastroenterol       Date:  2018-01-22       Impact factor: 7.527

5.  Willingness to pay for colorectal cancer screening in Guangzhou.

Authors:  Qin Zhou; Yan Li; Hua-Zhang Liu; Ying-Ru Liang; Guo-Zhen Lin
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

6.  Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.

Authors:  B Joseph Elmunzer; Amit G Singal; Jeremy B Sussman; Amar R Deshpande; Daniel A Sussman; Marisa L Conte; Ben A Dwamena; Mary A M Rogers; Philip S Schoenfeld; John M Inadomi; Sameer D Saini; Akbar K Waljee
Journal:  Gastrointest Endosc       Date:  2015-03       Impact factor: 9.427

7.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

8.  A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers.

Authors:  M Shuhaibar; C Walsh; F Lindsay; N Lee; P Walsh; P O'Gorman; G Boran; R McLoughlin; A Qasim; N Breslin; B Ryan; H O'Connor; C O'Morain
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

Review 9.  Colorectal cancer: from prevention to personalized medicine.

Authors:  Gemma Binefa; Francisco Rodríguez-Moranta; Alex Teule; Manuel Medina-Hayas
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

10.  Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore.

Authors:  Aesun Shin; Kyu-Won Jung; Young-Joo Won
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.